Clinical trial
Combination Chemotherapy in Treating Patients With Resected Colon Cancer
NCT00378716 · NSABP Foundation Inc, Other · Completed
Key facts
| NCT number | NCT00378716 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Resected Colon Cancer |
| Official title | A Clinical Trial Comparing Oral Uracil/Ftorafur (UFT) Plus Leucovorin (LV) With 5-Fluorouracil (5-FU) Plus LV in the Treatment of Patients With Stages II And III Carcinoma of the Colon |
| Lead sponsor | NSABP Foundation Inc, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | 5-fluorouracil, leucovorin calcium, tegafur, uracil |
| Enrollment | 1,608 |
| Start date | Feb 1, 1997 |
| Primary completion | May 1, 2006 |
| Completion | Apr 1, 2009 |
| First posted | Sep 21, 2006 |
| Last update posted | Jan 11, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: